Would you consider single agent TKI for patient with metastatic renal cell carcinoma who developed biopsy proven giant cell arteritis days after starting immunotherapy?  

Would active vasculitis present a contraindication to therapy?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Mackinac Straits Health System
Thank you.
Sign in or Register to read more